The Key to Lithium Dominance in the US 🔋

Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, guys and gals. It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Monday! It's September 19th. Let's get ready to trade! Markets 📈 US benchmarks slid on Friday. The S&P 500 posted a 0.7% loss, while the Nasdaq fell 0.9%. The Dow gave up half of a percentage point, and the small-cap Russell 2K sold off for 1.5%. This morning, futures are pointing to a lower open. Dow and S&P 500 contracts are both down 0.8% in early morning trading. Sponsored [The Key to Lithium Dominance in the US 🔋]( Nevada's desert flats contain more lithium than any other geography in the world. With electric vehicles driving a global boom in demand for lithium-ion batteries, Nevada should be on every investor's radar. There are several promising companies coming out of the state, but one stock is light years ahead of the competition. [Get the #1 Stock for Nevada's Lithium Bonanza Here]( Premarket Highlights 🔎 - Volkswagen has valued Porsche at $78 billion for its upcoming IPO. The offering will raise up to $9.4 billion, and Porsche shares will begin trading on Sept. 29th. - Bitcoin fell below $19,000 over the weekend, pulling back from its previous gains. - The London Stock Exchange is closed for Queen Elizabeth II's funeral and will reopen Tuesday at 8 a.m. local time. International 🌍 Asia The Nikkei 225 lost 1.1% overnight, while the Hang Seng Composite lost 1.0%. India's BSE Sensex was one of the region's only gainers after closing 0.5% higher. Europe France's CAC 40 is down 1.2%, and the German DAX is showing a 0.5% loss. The Euro Stoxx 600 is down 0.7%. Major Earnings 💰 AutoZone [AZO] ... AM Economy 🏗 - NAHB home builders' index [Sep] ... 10a Running Hot 🔥 Gainers - Senti Biosciences [SNTI] >> +38.8% - Foxo Tech [FOXO] >> +27.9% - Reunion Neurosciences [REUN] >> +88.6%% Decliners - Virios [VIRI] >> (64.8%) - Panbela Therapeutics [PBLA] >> (26.4%) - Ibio Inc [IBIO] >> (15.2%) AutoZone [AZO] - Last Close: $2,165.65 AutoZone is trending after a strong earnings report. The auto parts store posted stronger-than-expected sales, earnings, and growth in its fiscal Q4 earnings release. Autozone reported earnings of $40.51 per share, beating the Street's $38.47 target and marking substantial growth from last Q4's $35.72 EPS. Revenues of $5.35 billion also beat the $5.16 billion estimate and were up substantially from the year-earlier quarter's $4.91 billion. The report also showed same-store sales growth of 6.2%. AZO is one of the top S&P 500 stocks with a 2.3% gain. My Take: Autozone has a reputation for being a good "recession stock." The thought is, more people will fix their car themselves when money is tight. It's unclear if that will be the case this time around, but the company has shown it can still deliver when the economic chips are down. Knowbe4 [KNBE] - Last Close: $17.30 Knowbe4 is soaring on news of a potential buyout deal. This morning, the SaaS company confirmed it had received a non-binding proposal from Vista Equity Partners to acquire all outstanding shares of the company. Under the terms of the deal, Knowbe4 shareholders would receive $24 per share in cash for their holdings. Knowbe4's board is considering the proposal, but a formal decision has yet to be announced. KNBE is one of this morning's top performers with a 22.5% gain. My Take: There's still some upside left between this stock's current price point, and it's proposed acquisition price. If the deal is accepted, the stock could easily close the gap. However, there's no telling how far it could fall if the sale falls through. Purple Co [PRPL] - Last Close: $2.79 Purple is moving higher on buy-out news. The high-tech mattress-in-a-box company announced this morning that it had received an unsolicited, non-binding buyout proposal from Coliseum Capital Management. The proposal offers $4.35 apiece to acquire all outstanding capital stock of PRPL, representing a 55% upside from the stock's Friday closing price. Purple's board of directors says it will review the proposal, but a formal decision has yet to be announced. PRPL is trading actively with a 33.0% gain on the potential buyout news. My Take: An entry at this price point could backfire if the deal doesn't go through. However, there's still 15%+ upside if it all works out. BlueBird Bio Inc [BLUE] - Last Close: $6.34 BlueBird is moving higher after announcing a regulatory breakthrough. The biotech company said late Friday that the US Food & Drug Administration granted accelerated approval to its Skysona gene therapy, a treatment for a rare neurodegenerative disease in adolescent boys. BlueBird also announced regulators have lifted a previous clinical development hold on the drug. The company anticipates that the commercial product will be available by the end of 2022 through a limited number of qualified treatment centers in the US. BLUE shot out to a 17% gain when the news broke, but the rally has since cooled off a tad. BLUE is trading actively with a 6.9% gain. My Take: This rally seems a little underwhelming considering the small size of this stock's float and the importance of this FDA ruling. It seems like investors have a nagging concern here, but I'm not sure what it is. This could be a good entry point for a swing trade. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](